
DarioHealth Corp. DRIO
$ 11.3
-5.6%
Quarterly report 2025-Q3
added 11-13-2025
Country |
|
IPO year |
- |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ CAPITAL |
Shares |
28.4 M |
Market Cap[1] |
$ 321 M |
EBITDA (LTM) |
$ -36.8 M |
P/E (LTM) |
1.41 |
P/S (LTM) |
13.36 |
EPS (LTM) |
8.19 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Agilent Technologies
A
|
$ 117.99 | -2.79 % | $ 35.9 B | NYSE,SPB | ||
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market | ||
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market | ||
|
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | ||
|
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | ||
|
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | ||
|
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market | ||
|
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | ||
|
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | ||
|
Co-Diagnostics
CODX
|
- | - | $ 79.8 M | Nasdaq Capital Market | ||
|
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | ||
|
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | ||
|
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market | ||
|
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | ||
|
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | ||
|
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | ||
|
Laboratory Corporation of America Holdings
LH
|
$ 286.28 | -0.98 % | $ 23.8 B | NYSE,SPB | ||
|
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | ||
|
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | ||
|
Biodesix
BDSX
|
$ 15.52 | 1.24 % | $ 2.01 B | Nasdaq Global Market | ||
|
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | ||
|
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | ||
|
Anixa Biosciences
ANIX
|
$ 2.92 | -2.18 % | $ 94.8 K | Nasdaq Capital Market | ||
|
BioNano Genomics
BNGO
|
$ 1.14 | -0.87 % | $ 1.45 M | Nasdaq Capital Market,SPB | ||
|
Burning Rock Biotech Limited
BNR
|
$ 25.65 | -0.7 % | $ 272 M | Nasdaq Global Market | ||
|
Bioventus
BVS
|
$ 8.65 | -1.54 % | $ 542 M | Nasdaq Global Select Market | ||
|
Brainsway Ltd.
BWAY
|
$ 23.67 | 2.29 % | $ 99.4 M | Nasdaq Global Select Market | ||
|
CareDx, Inc
CDNA
|
$ 18.74 | -0.11 % | $ 999 M | Nasdaq Global Market,SPB | ||
|
Celcuity
CELC
|
$ 109.73 | -1.77 % | $ 4.33 B | Nasdaq Global Select Market | ||
|
Charles River Laboratories International
CRL
|
$ 175.58 | -1.63 % | $ 8.7 B | NYSE,SPB | ||
|
Castle Biosciences
CSTL
|
$ 27.91 | -5.61 % | $ 775 M | Nasdaq Global Market,SPB | ||
|
Quest Diagnostics Incorporated
DGX
|
$ 210.76 | -0.54 % | $ 23.4 B | NYSE,SPB | ||
|
Danaher Corporation
DHR
|
$ 205.45 | -2.46 % | $ 146 B | NYSE,SPB | ||
|
DexCom
DXCM
|
$ 72.42 | -1.38 % | $ 28.3 B | Nasdaq Global Select Market,SPB | ||
|
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | ||
|
Exact Sciences Corporation
EXAS
|
$ 103.41 | 0.02 % | $ 19.5 B | Nasdaq Capital Market,SPB | ||
|
Fulgent Genetics
FLGT
|
$ 14.19 | -7.47 % | $ 429 M | Nasdaq Global Market | ||
|
Guardant Health
GH
|
$ 92.44 | -1.56 % | $ 11.6 B | Nasdaq Global Select Market,SPB | ||
|
ICON Public Limited Company
ICLR
|
$ 107.18 | -0.89 % | $ 8.84 B | Nasdaq Global Select Market,SPB | ||
|
IDEXX Laboratories
IDXX
|
$ 634.55 | -3.38 % | $ 51 B | Nasdaq Global Select Market,SPB | ||
|
Illumina
ILMN
|
$ 130.56 | -2.9 % | $ 20.8 B | Nasdaq Global Select Market,SPB | ||
|
IQVIA Holdings
IQV
|
$ 172.81 | -3.37 % | $ 29.7 B | NYSE,SPB | ||
|
Interpace Biosciences
IDXG
|
$ 1.81 | 1.46 % | $ 7.94 M | Nasdaq Global Select Market | ||
|
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | ||
|
Organovo Holdings
ONVO
|
- | -2.3 % | $ 19.4 M | Nasdaq Capital Market | ||
|
OpGen
OPGN
|
- | -16.95 % | $ 1.54 M | Nasdaq Capital Market | ||
|
Lantheus Holdings
LNTH
|
$ 75.67 | 1.01 % | $ 5.11 B | Nasdaq Global Select Market,SPB | ||
|
Medpace Holdings
MEDP
|
$ 447.91 | -0.85 % | $ 12.9 B | Nasdaq Global Select Market,SPB | ||
|
Mettler-Toledo International
MTD
|
$ 1 323.31 | -3.17 % | $ 27.3 B | NYSE,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.